Mirian Gom 
ABUJA, Nigeria – The National Agency for Food and Drug Administration and Control (NAFDAC) has withdrawn, suspended, or cancelled 101 pharmaceutical products, effective immediately.
In a statement released on its official X handle Tuesday, the agency declared the affected medicines “no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale, or use within Nigeria.”
The full list is available on the NAFDAC website and includes widely used drugs such as Abacavir, Amlodipine, valsartan-based products, antimalarials like artemether/lumefantrine, and diabetes medicines such as Januvia and Janumet. Growth-hormone injectables and insulin formulations were also affected.
“The Certificate of Registration of a product may be withdrawn when its use is discontinued at the request of the Market Authorisation Holder,” NAFDAC explained. “Suspension occurs when licensing conditions are no longer met, while cancellation means revocation by the agency.”
Health experts say the move follows global concern over counterfeit and substandard medicines.
WHO estimates show up to 10 per cent of medicines in low- and middle-income countries are falsified or poor quality.
“We are committed to ensuring only safe, effective medicines remain in circulation,” NAFDAC stressed.
The agency urged Nigerians to verify drugs through its Med Safety App and other authentication platforms.
About the Author
Hussaini Ibrahim 
